Updated:
Spark Therapeutics, Inc.
Spark Therapeutics, Inc. is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001609351, and its reported...
Overview
Spark Therapeutics, Inc. is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001609351, and its reported industry is Biological Products, (No Diagnostic Substances). In 10-K filed on 2019-02-28, it reported annual revenue of USD 64,725,000; net income of USD -78,822,000; total assets of USD 814,352,000 for the fiscal period ended 2018-12-31. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.
Company overview
- Legal name
- Spark Therapeutics, Inc.
- Classification
- Company
- Industry (SIC)
- 2836 — Biological Products, (No Diagnostic Substances)
- Headquarters
- Philadelphia, PA, United States
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 0001609351
Financials
Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.
| Fiscal year | Period end | Revenue | Net income | Total assets | Cash and equivalents | Operating cash flow |
|---|---|---|---|---|---|---|
| FY2018USD | $64.7M | -$78.8M | $814.4M | $95.2M | -$70.6M | |
| FY2017USD | $12.1M | -$253.5M | $616.8M | $96.7M | — | |
| FY2016USD | $20.2M | -$123.7M | $373.9M | $58.9M | — | |
| FY2015USD | $22.1M | -$47.1M | $329.8M | $293.5M | — |
FY2017. Net income, Total assets, Cash and equivalents: shown as originally filed; later filings report different values for the same periods.
FY2016. Net income, Cash and equivalents: shown as originally filed; later filings report different values for the same periods.
Recent SEC filings
| Form | Filed | Period | Filing |
|---|---|---|---|
| 8-K | FORM 8-K | ||
| 10-Q | 10-Q | ||
| 8-K | 8-K | ||
| 10-Q | 10-Q | ||
| DEF 14A | DEF 14A | ||
| 8-K | FORM 8-K | ||
| 10-Q | 10-Q | ||
| 10-K/A | 10-K/A | ||
| 10-K | 10-K | ||
| 8-K | FORM 8-K | ||
| 8-K | 8-K - EARNINGS RELEASE | ||
| 8-K | 8-K JP MORGAN 2019 |
Profile maintained by Altss. Updated: . To correct this record or make a privacy request, send the page URL and your evidence to privacy@altss.com; corrections are free.
Research Spark Therapeutics, Inc. in Altss
Track this company’s investors, transactions and relationships in Altss.